ASX:MDC Medlab Clinical (MDC) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Medlab Clinical Stock (ASX:MDC) 30 days 90 days 365 days Advanced Chart Get Medlab Clinical alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume36,677 shsAverage VolumeN/AMarket CapitalizationA$15.07 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Medlab Clinical Limited, a biotechnology company, researches, develops, and pre-commercializes pharmaceutical and nutraceutical products in Australia. Its drug candidate includes NanaBis, a buccal spray from cannabis oil extract for oncology and pain management; and NanoCBD, a buccal spray from hemp oil extract for mental health. The company also develops NanoCelle, a patented sub-micron drug delivery platform that allows passive diffusion of active pharmaceutical ingredients directly into the bloodstream through oral-buccal, sublingual, intranasal, and transdermal or topical delivery. In addition, it offers virtual clinic services. The company was founded in 2012 and is headquartered in Botany, Australia. Read More Receive MDC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medlab Clinical and its competitors with MarketBeat's FREE daily newsletter. Email Address MDC Stock News HeadlinesMedlab Clinical to be Delisted from ASXFebruary 27, 2025 | tipranks.comMedlab Clinical Reports Q2 2025 Financials Amidst Strategic ChangesFebruary 2, 2025 | tipranks.comA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. July 9 at 2:00 AM | Porter & Company (Ad)Medlab Clinical Faces Steep Revenue Decline and LossNovember 3, 2024 | markets.businessinsider.comChild Care on College Campuses: What to KnowOctober 24, 2024 | usnews.comMedlab West Africa - the Biggest Medical Lab Event in the Region Returns to LagosApril 16, 2024 | msn.comClinical Laboratory Technician SalaryMay 20, 2023 | money.usnews.comHealthKick Podcast: Aussie Bio Tech Medlab is confident in highly anticipated Phase III trialFebruary 13, 2023 | msn.comSee More Headlines MDC Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Medlab Clinical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Medlab Clinical investors own include Magellan Financial Group (MFG), iSignthis (ISX), FBR (FBR), Embark Early Education (EVO), Dacian Gold (DCN), Constellation Technologies (CT1) and Bod Australia (BDA). Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Biotechnology Sub-IndustryConstruction Current SymbolASX:MDC CIKN/A Webwww.medlab.co Phone61 2 8188 0311FaxN/AEmployees1,640Year FoundedN/AProfitability EPS (Trailing Twelve Months)A($547.50) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-A$3.94 million Net Margins-1,351.41% Pretax MarginN/A Return on Equity12,575.02% Return on Assets-79.67% Debt Debt-to-Equity RatioN/A Current Ratio0.35 Quick Ratio3.71 Sales & Book Value Annual Sales-A$1.47 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow5.12 Book ValueA($0.31) per share Price / BookN/AMiscellaneous Outstanding Shares2,280,000Free FloatN/AMarket CapA$15.07 million OptionableNot Optionable Beta0.89 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free Report This page (ASX:MDC) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medlab Clinical Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Medlab Clinical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
